1.370RON+2.24%Mkt Cap: 294.94M $P/E: 15.221d ago
Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT,…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap294.94M $
Enterprise Value244.60M $
Revenue (TTM)69.20M $
Gross Profit59.62M $
Net Income (TTM)21.99M $
Revenue/Share0.0701 USD
Last Price1.370 RON
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees374
CountryRO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINROBIOFACNOR9
Valuation
P/E (Trailing)15.22
P/E (Forward)—
PEG—
EV/EBITDA9.73
EV/Revenue3.53
P/S4.26
P/B2.32
EPS (TTM)0.09
EPS (Forward)—
52W Range
0.782082% of range1.495
52W High1.495 RON
52W Low0.7820 RON
Profitability
Gross Margin85.46%
Oper. Margin38.40%
EBITDA Margin36.32%
Profit Margin31.51%
ROE18.35%
ROA15.80%
Growth
Revenue Growth-2.70%
Earnings Growth0.60%
Cash Flow & Leverage
Operating CF17.59M $
CapEx (TTM)3.20M $
FCF Margin18.33%
FCF Yield4.30%
Net Debt-50.33M $
Net Debt/EBITDA-2.00
Balance Sheet
Debt/Equity0.00
Current Ratio4.93
Quick Ratio4.22
Book Value/Sh0.5900 RON
Cash/Share0.2350 RON
Dividends
Fwd Div Rate0.0400 RON
Trail. Div Rate0.0420 RON
Div. Yield3.13%
5Y Avg Yield3.64%
Payout Ratio33.59%
Ex-Div DateJun 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.985.37M
Float476.14M
Insiders0.00%
Institutions88.43%
Technical
SMA 501.427 (-4.0%)
SMA 2001.124 (+21.9%)
Beta0.51
S&P 52W Chg20.25%
Avg Vol (30d)213.43K
Avg Vol (10d)134.45K
Technical Indicators
RSI (14)42.4
MACD-0.0214
MACD Signal-0.0152
MACD Hist.-0.0062
BB Upper1.526 RON
BB Middle1.405 RON
BB Lower1.285 RON
BB Width17.15%
ATR (14)0.0220 RON
Vol Ratio (20d)0.19x